|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.90 USD | -0.19% |
|
-2.82% | -35.41% |
| Capitalization | 12.8B 11B 10.3B 9.6B 17.74B 1,152B 19.29B 121B 46.54B 544B 48.02B 47B 1,989B | P/E ratio 2026 * |
18.4x | P/E ratio 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise value | 15.83B 13.61B 12.75B 11.88B 21.94B 1,424B 23.87B 149B 57.56B 673B 59.4B 58.14B 2,460B | EV / Sales 2026 * |
2.44x | EV / Sales 2027 * | 2.33x |
| Free-Float |
94.01% | Yield 2026 * |
4.75% | Yield 2027 * | 4.93% |
Last Transcript: The Clorox Company
| 1 day | -0.19% | ||
| 1 week | -2.82% | ||
| Current month | -2.82% | ||
| 1 month | -1.30% | ||
| 3 months | -17.42% | ||
| 6 months | -17.85% | ||
| Current year | -35.41% |
| 1 week | 104.62 |  | 107.99 |
| 1 month | 98.2 | | 108.18 |
| Current year | 98.2 | | 164.22 |
| 1 year | 98.2 | | 169.61 |
| 3 years | 98.2 | | 178.2 |
| 5 years | 98.2 | | 231.11 |
| 10 years | 98.2 | | 239.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Rendle
CEO | Chief Executive Officer | 47 | 2020-09-13 |
Luc Bellet
DFI | Director of Finance/CFO | 47 | 2025-03-31 |
Chau Banks
CTO | Chief Tech/Sci/R&D Officer | 56 | 2020-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Esther Lee
BRD | Director/Board Member | 66 | 2013-08-18 |
| Director/Board Member | 67 | 2015-06-30 | |
Allan Mackay
BRD | Director/Board Member | 70 | 2016-08-14 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | -2.82% | -37.17% | -28.62% | 12.8B | |
| +1.05% | +1.98% | +24.98% | -0.33% | 53.52B | |
| +0.68% | -0.75% | -21.16% | +5.07% | 20.3B | |
| -2.17% | +4.23% | +44.53% | -42.83% | 6.16B | |
| -0.58% | -3.88% | -12.47% | -23.99% | 5.05B | |
| -0.40% | -3.11% | -12.47% | +10.01% | 2.86B | |
| -1.31% | -2.59% | -30.34% | +13.96% | 2.58B | |
| +4.07% | +3.29% | +15.68% | +75.65% | 1.44B | |
| -1.17% | -3.36% | -31.42% | +39.49% | 1.18B | |
| +0.59% | -3.03% | +13.98% | +202.65% | 820M | |
| Average | +0.06% | -0.95% | -4.59% | +25.11% | 10.67B | |
| Weighted average by Cap. | +0.48% | +0.38% | +4.93% | -2.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.5B 5.58B 5.23B 4.88B 9.01B 585B 9.8B 61.18B 23.62B 276B 24.38B 23.86B 1,010B | 6.81B 5.85B 5.48B 5.11B 9.43B 612B 10.26B 64.1B 24.75B 289B 25.54B 25B 1,058B |
| Net income | 703M 605M 566M 528M 975M 63.3B 1.06B 6.62B 2.56B 29.89B 2.64B 2.58B 109B | 797M 685M 642M 598M 1.11B 71.76B 1.2B 7.51B 2.9B 33.89B 2.99B 2.93B 124B |
| Net Debt | 3.03B 2.61B 2.44B 2.28B 4.2B 273B 4.57B 28.56B 11.03B 129B 11.38B 11.14B 471B | 3.05B 2.62B 2.45B 2.29B 4.22B 274B 4.6B 28.71B 11.08B 130B 11.44B 11.19B 474B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 104.90 $ | -0.19% | 1,384,451 |
| 25-12-04 | 105.10 $ | -0.07% | 1,367,873 |
| 25-12-03 | 105.17 $ | -0.68% | 1,670,126 |
| 25-12-02 | 105.89 $ | -0.49% | 2,130,780 |
| 25-12-01 | 106.41 $ | -1.42% | 1,982,031 |
Delayed Quote Nyse, December 05, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CLX Stock
Select your edition
All financial news and data tailored to specific country editions
